China Independent Clinical Laboratory Industry Report, 2016-2020

Publisher Name :
Date: 21-Sep-2016
No. of pages: 135

Owing to a large population base, uneven distribution of medical resources among regions, aging population, and continuous advance of health care reform, the Chinese independent clinical laboratory market size has been growing radically in recent years, reaching about RMB6.5 billion with a year-on-year increase of 37.4% in 2015; it is expected to grow rapidly at a rate of 30%-40% over the next three to five years and report RMB29.2 billion in 2020.

There are approximately200 independent clinical laboratory enterprises in China, mainly comprehensive diagnostic chains and special diagnostic enterprises. KingMed Diagnostics, Dian Diagnostics, ADICON Clinical Laboratories, and DaAn Health (invested by Da An Gene), which hold a combined market share of 70% and all adopt chain-based model of comprehensive diagnostic services. By the end of 2015, the four enterprises separately had 31, 26, 20 and 8 independent clinical laboratories. While expanding clinical laboratory services actively, all companies are deploying " laboratory +" industrial chain vigorously.

As a titan in China independent clinical laboratory industry, KingMed Diagnostics earned the revenue of RMB2.5 billion to RMB3 billion in 2015 with 40% market share. In the past two years, KingMed Diagnostics has been involved in production and sale of in vitro diagnostic products through acquisitions and independent R & D; moreover, it has made layout on "laboratory + Internet" services by acquiring GoHeath (Guangzhou Jinzhun), access to Tmall’s online pharmacies, etc..

Second to KingMed Diagnostics, Dian Diagnostics gained the revenue of RMB1.079 billion from independent clinical laboratory in 2015. In recent years, the company has implemented the strategy of horizontal expansion, vertical digging, technological innovation and industrial chain integration aggressively. It has arranged the " diagnosis +" ecosystem which refers to the expansion of other related services such as health management, judicial diagnostics, medicine CRO, cold chain logistics and mobile health with a focus on "diagnostic services + products". Since November 2015, the company has acquired Freda,Yuanding, ShengshiKehua, Faith Medical, Kingpe and many other high-quality IVD distributors for over RMB1 billion totally. In 2015, the company launched a new mode for chain expansion of physical examination services -- a health management center (Hangzhou Full-process International Health Medical Management Center Co., Ltd.) established with Hangzhou Jiebai, Baida Group. Meanwhile, Dian Diagnostics signed strategic cooperation agreements with The Johns Hopkins Hospital and AliHealth respectively to explore the "diagnosis + Internet" business mode energetically. At the beginning of 2016, Dian Diagnostics collaborated with Tigermed to set up a joint venture -- Shanghai Teddy Medical Institute Co., Ltd., marking the former’s foray into pharmaceutical CRO.

The third-ranked ADICON Clinical Laboratories which still enjoys superiority in East China has not realized the distribution of nationwide chain operation, but its special laboratory items have showed strong competitiveness. The company is not only authorized by the global pharmaceutical giant Roche to become "Roche’s Demonstration Laboratory in China", but also cooperates with Siemens Healthineers, Japan SRL, South Korea SCL, France Bio Mérieux, etc. in medical diagnostics.

Being bullish about the prospects of the Chinese independent clinical laboratory market, a number of small and medium Chinese independent clinical laboratory companies have drawn or plan to draw support fromthe capital market to further expand the clinical laboratory market. In 2014-mid-2016, Surexam Biotechnology, Shanghai Labway, Beijing Lepu, Shanghai Biotecan, Jiangsu Superbio, Beijing Lawke and other companies went public at NEW OTCBB in China. Wherein, Jiangsu Superbio witnessed the fastest revenue growth in clinical laboratory, namely the year-on-year surge of 161.0% in 2015; Shanghai Biotecan took the second place with the CAGR of 92.1% in 2013-2015. Shanghai Labway Clinical Laboraory obtained the clinical laboratory revenue of RMB127.8 million in 2015, but the revenue growth has slowed down due to the construction and expansion of laboratories in recent years.

China Independent Clinical Laboratory Industry Report, 2016-2020 highlights the followings:


  • Policy environment, international market, development status, and competitive landscape of China’s independent clinical laboratory industry;

  • Upstream and downstream markets of China’s independent clinical laboratory industry and their impacts;

  • Operation, and independent clinical laboratory business of 19 relevant enterprises in China;

  • Development outlook of China’s independent clinical laboratory industry in 2016-2020 and operational comparison among key players.

China Independent Clinical Laboratory Industry Report, 2016-2020

Table of Contents

1. Overview of Independent Clinical Laboratory
1.1 Definition
1.2 Industry Chain

2. Overview of China Independent Clinical Laboratory Industry
2.1 Policy Environment
2.1.1 Access Policy
2.1.2 Industry Policy
2.2 International Market
2.2.1 Status Quo
2.2.2 Benchmarking Enterprises
2.3 Development
2.4 Competitive Landscape

3. Upstream and Downstream Markets of China Independent Clinical Laboratory Industry
3.1 Upstream Market
3.1.1 Status Quo
3.1.2 Competition Pattern
3.2 Downstream Market
3.2.1 Independent Clinical Laboratory Market Sees Huge Capacity
3.2.2 Healthcare Reform Boosts the Rapid Development of Independent Clinical Laboratory Market
3.2.3 Demand Diversification Promotes the Upgrading of Independent Clinical Laboratory Industry
3.2.4 Healthcare Demand Growth Propels the Independent Clinical Laboratory Forward Faster
3.2.5 Internet Will Stimulate the Business Model Upgrade of Independent Clinical Laboratory Industry

4. Key Players
4.1 KingMed Diagnostics
4.1.1 Profile
4.1.2 Operation
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 R&D and Investment
4.1.6 Independent Clinical Laboratory
4.1.7 Client and Supplier
4.1.8 Forecast and Outlook
4.2 ADICON
4.2.1 Profile
4.2.2 Independent Clinical Laboratory
4.2.3 Development
4.3 Dian Diagnostics
4.3.1 Profile
4.3.2 Operation
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 R&D and Investment
4.3.6 Independent Clinical Laboratory
4.3.7 Client and Supplier
4.3.8 Forecast and Outlook
4.4 DAAN Gene
4.4.1 Profile
4.4.2 Operation
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 R&D and Investment
4.4.6 Independent Clinical Laboratory
4.4.7 Client and Supplier
4.4.8 Forecast and Outlook
4.5 Shanghai Labway Clinical Laboratory Co., Ltd.
4.5.1 Profile
4.5.2 Operation
4.5.3 Revenue Structure
4.5.4 Gross Margin
4.5.5 R&D and Investment
4.5.6 Independent Clinical Laboratory
4.5.7 Client and Supplier
4.5.8 Forecast and Outlook
4.6 NYMPHAVN Biotechnology
4.6.1 Profile
4.6.2 Operation
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 R&D and Investment
4.6.6 Independent Clinical Laboratory
4.6.7 Forecast and Outlook
4.7 SurExam Bio-Tech Co., Ltd.
4.7.1 Profile
4.7.2 Operation
4.7.3 Revenue Structure
4.7.4 Gross Margin
4.7.5 R&D and Investment
4.7.6 Independent Clinical Laboratory
4.7.7 Client and Supplier
4.7.8 Forecast and Outlook
4.8 Ningbo Medicalsystem Biotechnology Co., Ltd.
4.8.1 Profile
4.8.2 Operation
4.8.3 Revenue Structure
4.8.4 Gross Margin
4.8.5 R&D and Investment
4.8.6 Independent Clinical Laboratory
4.8.7 Client and Supplier
4.8.8 Forecast and Outlook
4.9 Beijing Lawke Health Laboratory Co., Ltd.
4.9.1 Profile
4.9.2 Operation
4.9.3 Revenue Structure
4.9.4 Gross Margin
4.9.5 Forecast and Outlook
4.10 Beijing Lepu Gene Technology Co.,Ltd.
4.10.1 Profile
4.10.2 Operation
4.10.3 Gross Margin
4.10.4 Forecast and Outlook
4.11 Shanghai Biotecan Pharmaceuticals Co., Ltd.
4.11.1 Profile
4.11.2 Operation
4.11.3 Revenue Structure
4.11.4 Gross Margin
4.11.5 Independent Clinical Laboratory
4.11.6 Forecast and Outlook
4.12 Jiangsu Superbio Life Science Co., Ltd.
4.12.1 Profile
4.12.2 Operation
4.12.3 Revenue Structure
4.12.4 Gross Margin
4.12.5 Client and Supplier
4.12.6 Forecast and Outlook
4.13 Other Enterprises
4.13.1 Kindstar Global
4.13.2 Xiamen Amoy Diagnostics Co., Ltd.
4.13.3 CapitalBio Corporation
4.13.4 Beijing Adinovo Technologies Co., Ltd.
4.13.5 Beijing Deyi Diagnostics Technology Co., Ltd.
4.13.6 IPE Biotechnology Co., Ltd.
4.13.7 Centre Testing International

5. Forecast and Outlook
5.1 Industry Development
5.2 Operation Comparison between Enterprises
5.2.1 Revenue
5.2.2 Gross Margin

List of Charts

Independent Clinical Laboratory Industry Chain
Comparison of Independent Clinical Laboratory Undertakers between China and USA
Policies Concerning Independent Clinical Laboratory Industry in China, 2010-2016
Market Share of Independent Clinical Laboratories in Major Countries
U.S. Independent Clinical Laboratory Market Share by Test Item
U.S. Clinical Laboratory Market Share by Demand Side
Revenue and Net Income of Quest, 2009-2016
Revenue of Quest Diagnostics by Business, 2014-2015
Major M&As of Quest Diagnostics, 2006-2015
Revenue and Operating Income of LabCorp, 2010-2016
Revenue Breakdown of LabCorp by Business, 2013-2016
Major M&As of LabCorp, 2007-2015
Market Scale of independent clinical laboratory industry in China,2013-2016
Revenue CAGR of Some Independent Clinical Laboratory Enterprises in China, 2012-2015
Market Share of Major Enterprises in China’s Independent Clinical Laboratory Industry, 2015
Basic Characteristics and Market Share of Major Independent Clinical Laboratory Enterprises in China, 2015
Development History of In Vitro Diagnostic Industry in China
Market Size of In Vitro Diagnostic Industry in China, 2009-2015
Market Structure of In Vitro Diagnostic Reagent Industry in China, 2015
Comparison of Diagnostic Instrument Varieties between Domestic and Foreign Enterprises
Competition Pattern of Diagnostic Reagent Industry in China
IVD Revenue and Market Share of Major Diagnostic Reagent Enterprises in China, 2013-2015
Business Revenue and Inspection Revenue of Public Hospitals in China, 2014
Per Capita Inspection Fees and % of Outpatient Expenses of Outpatients in Chinese Hospitals, 2010-2014
Per Capita Inspection Fees and % of Hospitalization Expenses of Inpatients in Chinese Hospitals, 2010-2014
Business Revenue and Inspection Revenue of Public Hospitals in China by Type of Visit, 2014
Medical Services of Health Agencies in China, 2012-2015
Number of Medical Institutions in China, 2012-2015
Health Expenditure and % of GDP in China, 1980-2015
Per Capita Health Expenditure and YoY Growth in China, 2006-2015
Revenue and Net Income of KingMed Diagnostics, 2012-2015
Revenue Breakdown of KingMed Diagnostics by Business, 2012-2015
Revenue Breakdown of KingMed Diagnostics by Region, 2012-2015
Gross Margin of KingMed Diagnostics by Business, 2012-2015
R&D Costs and % of Total Revenue of KingMed Diagnostics, 2012-2015
Proposed Fundraising & Investment Projects and Value of KingMed Diagnostics, 2016
Distribution of Independent Clinical Laboratories of KingMed Diagnostics, as of June 2016
Capacity and Output of KingMed Diagnostics (by Business), 2014-2015
Service Prices of KingMed Diagnostics (by Business), 2012-2015
Revenue of Dian Diagnostics from Top 5 Clients and % in Total Revenue, 2012-2015
Revenue of KingMed Diagnostics from Top 5 Clients and % of Total Revenue, 2014-2015
Procurement of KingMed Diagnostics from Top 5 Suppliers and % of Total Procurement, 2014-2015
Revenue and Net Income of KingMed Diagnostics, 2015-2020
Revenue and Net Income of Dian Diagnostics, 2010-2016
Revenue Breakdown of Dian Diagnostics by Product, 2010-2016
Revenue Breakdown of Dian Diagnostics by Region, 2009-2016
Gross Margin of Dian Diagnostics, 2010-2016
Gross Margin of Dian Diagnostics by Product, 2010-2015
R&D Costs and % of Total Revenue of Dian Diagnostics, 2010-2016
Dian Diagnostics’ Revenue from Independent Clinical Laboratory and YoY Growth, 2009-2016
Revenue of Dian Diagnostics’ Top 5 Clients and % in Total Revenue, 2011-2016
Revenue of Dian Diagnostics from Top 5 Clients and % of Total Revenue, 2015-2016
Procurement of Dian Diagnostics’ Top 5 Suppliers and % in Total Procurement, 2011-2016
Procurement of Dian Diagnostics’ Top 5 Suppliers and % in Total Procurement, 2015-2016
Revenue and Net Income of Dian Diagnostics, 2015-2020E
Revenue and Net Income of Da An Gene, 2010-2016
Revenue Breakdown of Da An Gene by Business, 2010-2016
Revenue Breakdown of Da An Gene by Region, 2010-2016
Gross Margin of Da An Gene, 2010-2016
Gross Margin of Da An Gene by Business, 2010-2016
R&D Costs and % of Total Revenue of Da An Gene, 2011-2016
Main Assets and Business of Da An Gene
Industrial Chain Layout of Da An Gene
Medical Resources of Sun Yat-Sen University
Da An Gene’s Revenue from Independent Clinical Laboratory and YoY Growth, 2010-2016
Revenue of Da An Gene from Top 5 Clients and % in Total Revenue, 2014-2015
Top 5 Suppliers of Da An Gene, 2014-2015
Revenue and Net Income of Da An Gene, 2015-2020E
Revenue and Net Income of Shanghai Labway, 2013-2016
Revenue Breakdown of Shanghai Labway by Product, 2013-2016
Gross Margin of Shanghai Labway by Product, 2013-2016
R&D Costs and % of Medical Diagnosis Service’s revenue of Nymphavn Biotechnology, 2013-2016
Revenue from and Gross Margin of Independent Clinical Laboratory Business of Medicalsystem Biotechnology, 2013-2016
Revenue of Shanghai Labway’s Top 5 Clients and % in Total Revenue, 2013-2015
Revenue of Shanghai Labway’s Top 5 Clients and % in Total Revenue, 2015
Procurement of Shanghai Labway’ Top 5 Suppliers and % in Total Procurement, 2013-2015
Procurement of Shanghai Labway’ Top 5 Suppliers and % in Total Procurement, 2015
Revenue and Net Income of Nymphavn Biotechnology, 2009-2016
Revenue Breakdown of Nymphavn Biotechnology by Product, 2009-2016
Gross Margin of Nymphavn Biotechnology, 2009-2016
Gross Margin of Nymphavn Biotechnology by Product, 2009-2016
R&D Costs and % of Total Revenue of Nymphavn Biotechnology, 2011-2016
Revenue from and Gross Margin of Independent Clinical Laboratory Business of Nymphavn Biotechnology, 2009-2016
Revenue and Net Income of Nymphavn Biotechnology, 2015-2020E
Subsidiaries and Main Businesses of Surexam Biotechnology
Revenue and Net Income of Surexam Biotechnology, 2011-2016
Revenue Breakdown of Surexam Biotechnology by Business, 2011-2016
Gross Margin of Surexam Biotechnology, 2011-2016
Gross Margin of Surexam Biotechnology by Product, 2009-2016
R&D Costs and % of Total Revenue of Surexam Biotechnology, 2011-2016
Revenue from and Gross Margin of Independent Clinical Laboratory Business of Surexam Biotechnology, 2011-2016
Revenue of Surexam Biotechnology from Top 5 Clients and % of Total Revenue, 2015
Procurement of Surexam Biotechnology from Top 5 Suppliers and % of Total Procurement, 2015
Revenue and Net Income of Surexam Biotechnology, 2015-2020E
Revenue and Net Income of Medicalsystem Biotechnology, 2011-2016
Revenue Breakdown of Medicalsystem Biotechnology by Product, 2011-2016
Gross Margin of Medicalsystem Biotechnology by Product, 2011-2016
R&D Costs and % of Total Revenue of Medicalsystem Biotechnology, 2011-2016
Projects Proposed/Under Construction of Medicalsystem Biotechnology
Revenue from and Gross Margin of Independent Clinical Laboratory Business of Medicalsystem Biotechnology, 2011-2016
Revenue of Medicalsystem Biotechnology’ Top 5 Clients and % in Total Revenue, 2011-2016
Procurement of Medicalsystem Biotechnology’ Top 5 Suppliers and % in Total Procurement, 2011-2016
Revenue and Net Income of Medicalsystem Biotechnology, 2015-2020E
Revenue and Net Income of Beijing Lawke, 2013-2016
Revenue Breakdown of Beijing Lawke by Region, 2014-2016
Gross Margin of Beijing Lawke by Business, 2013-2016
Revenue and Net Income of Beijing Lawke, 2015-2020E
Revenue and Net Income of Lepu Gene, 2013-2016
Gross Margin of Lepu Gene,2013-2016
Revenue and Net Income of Lepu Gene, 2015-2020E
Revenue and Net Income of Biotecan,2013-2016
Revenue Breakdown of Shanghai Biotecan by Business 2014-2016
Gross Margin of Shanghai Biotecan, 2014-2016
Clinical Laboratory Revenue of Shanghai Biotecan and % of Total Revenue, 2013-2016
Revenue and Net Income of Biotecan, 2015-2020E
Revenue and Net Income of Jiangsu Superbio, 2014-2015
Revenue Breakdown of JiangsuSuperbio by Business,2014-2015
Revenue Breakdown of S Jiangsu Superbio by Region,2014-2015
Gross Margin of Jiangsu Superb by business,2014-2015
Revenue of Jiangsu Superb from Top 5 Clients and % of Total Revenue, 2014-2015
Procurement of Jiangsu Superb from Top 5 Suppliers and % of Total Procurement, 2014-2015
Revenue and Net Income of Jiangsu Superbio, 2015-2020
Milestones of Kindstar Global
Some Strategic Partners of ADINOVO
Chinese Independent Clinical Laboratory Market Size and YoY Growth, 2014-2020E
Revenue of Major Independent Clinical Laboratory Enterprises in China, 2011-2016
Clinical Laboratory Revenue of Major Enterprises in Independent Clinical Laboratory Industry in China, 2012-2016
Gross Margin of Major Enterprises in Independent Clinical Laboratory Industry in China, 2012-2016
Gross Margin of Clinical Laboratory Business of Major Independent Clinical Laboratory Enterprises in China, 2012-2016

  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • 2017 Flow Cytometry Analyzers and Strategic Profiles of Leading Suppliers
    Published: 24-Jan-2017        Price: US 2850 Onwards        Pages: 40
    This 40-page report reviews current instrumentation technologies, and compares features of leading flow cytometry analyzers.The report also presents strategic assessments of current and emerging suppliers of hematology and flow cytometry analyzers and consumables, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.Contains 40 pages......
  • 2017 Hematology and Flow Cytometry Analyzers, and Strategic Profiles of Leading Suppliers
    Published: 24-Jan-2017        Price: US 3850 Onwards        Pages: 65
    This 65-page report reviews current instrumentation technologies, and compares features of leading hematology and flow cytometry analyzers.The report also presents strategic assessments of current and emerging suppliers of hematology and flow cytometry products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.Contains 65 pages......
  • 2017-2021 Europe Flow Cytometry Market: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
    Published: 18-Jan-2017        Price: US 13700 Onwards        Pages: 270
    This unique report provides information not available from any other published source, including test volume forecasts, instrument placements and installed base by manufacturer and model, as well as sales and market shares of leading instrument and reagents suppliers.This 5-country report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the flow cytometry markets during the next five years.  The report explores future market......
  • United States Flow Cytometry Instrumentation Market Report 2017
    Published: 13-Jan-2017        Price: US 3800 Onwards        Pages: 104
    Notes: Sales, means the sales volume of Flow Cytometry Instrumentation Revenue, means the sales value of Flow Cytometry Instrumentation This report studies sales (consumption) of Flow Cytometry Instrumentation in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Beckman Coulter/Danaher - BD - Bio-Rad Laboratories - Sysmex - EMD Millipore - Luminex Corpora......
  • Global Flow Cytometry Instrumentation Sales Market Report 2017
    Published: 12-Jan-2017        Price: US 4000 Onwards        Pages: 103
    Notes: Sales, means the sales volume of Flow Cytometry Instrumentation Revenue, means the sales value of Flow Cytometry Instrumentation This report studies sales (consumption) of Flow Cytometry Instrumentation in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Beckman Coulter/Danaher - BD ......
  • China Flow Cytometry Instrumentation Market Research Report 2017
    Published: 11-Jan-2017        Price: US 3200 Onwards        Pages: 100
    Notes: Sales, means the sales volume of Flow Cytometry Instrumentation Revenue, means the sales value of Flow Cytometry Instrumentation This report studies Flow Cytometry Instrumentation in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - - Beckman Coulter/Danaher - - BD - - Bio-Rad Laboratories - - Sysmex - - EMD Millipore -......
  • Global Flow Cytometry Instrumentation Market Research Report 2016
    Published: 23-Dec-2016        Price: US 2900 Onwards        Pages: 107
    Notes: Production, means the output of Flow Cytometry Instrumentation Revenue, means the sales value of Flow Cytometry Instrumentation This report studies Flow Cytometry Instrumentation in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Beckman Coulter/Danaher - BD - Bio-Rad ......
  • Global Cell Countes Sales Market Report 2016
    Published: 12-Dec-2016        Price: US 4000 Onwards        Pages: 111
    Notes: Sales, means the sales volume of Cell Countes Revenue, means the sales value of Cell Countes This report studies sales (consumption) of Cell Countes in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Paul Marienfeld - Synbiosis - Interscience - Hecht Assistant - Chemomet......
  • Flow Cytometry 2017-2021: Laboratory Universe, Specimen/Test Volume and Sales Forecasts by Country
    Published: 09-Dec-2016        Price: US 1850 Onwards        Pages: 9
    This report provides a worldwide overview of the flow cytometry markets, including estimates of testing facilities, specimen and test volume, as well as reagent and instrument sales forecasts by country.Contains 9 pages and 4 tables......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs